Pig Models Valuable Tools for Biomedical Research

Genetically engineered pigs, minipigs and microminipigs are valuable tools for biomedical research.

Their lifespan, anatomy, physiology, genetic make-up, and disease mechanisms are more similar to humans than the rodent models typically used in drug discovery research.

Genetics Could Influence Whether Ebola Will be Fatal
A study on mice has suggested that genetics may play a role in the severity of the Ebola virus.

A Comprehensive Review article entitled "Current Progress of Genetically Engineered Pig Models for Biomedical Research," describing advances in techniques to create and use pig models and their impact on the development of novel drugs and cell and gene therapies, is published in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

The article is available on the BioResearch Open Access website at http://online.liebertpub.com/doi/full/10.1089/biores.2014.0039.

Gökhan Gün and Wilfried Kues, Friedrich-Loeffler-Institute (Neustadt, Germany), Istanbul Technical University, and Istanbul University Faculty of Veterinary Medicine (Turkey), discuss the technologies that have made it possible to develop transgenic pig models of human diseases, such as targeted gene transfer and genome sequencing.

Metabolic Genetics Research can Give Direction to New Treatments
Studying specific proteins and the genes that encode them could help scientists develop new drugs that directly target the faulty metabolic processes.

The authors review current progress in creating transgenic pig models for cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, ophthalmology, and xenotransplantation. These models will enable researchers to study disease processes, identify new drug targets, test novel cell therapies to restore diseased tissues and organs, and assess methods to correct or replace mutated genes.

"This review provides an excellent update of recent progress in the field of pig transgenics for biomedical research," says BioResearch Open Access Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland.

Myriad Genetics Presents Tumor BRACAnalysis CDx Study
Myriad Genetics, Inc. (Nasdaq: MYGN) announced that its Tumor BRACAnalysis CDx™ companion diagnostic test significantly improved the detection of cancer-causing BRCA1/2 mutations by 44 percent in ovarian cancer patients.

Source-Eurekalert

Environment Determines Food Allergic Disease More Than Genetics
Environment has a much stronger role than genetics in eosinophilic esophagitis (EoE), a severe, often painful food allergy that renders children unable to eat a variety of foods.